A5015923637- Liver Disease Diagnosis and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Eosinophilic Esophagitis
- Glioma Diagnosis and Treatment
- Vascular Procedures and Complications
- Asthma and respiratory diseases
- Meta-analysis and systematic reviews
- Respiratory Support and Mechanisms
- Child and Adolescent Psychosocial and Emotional Development
- Liver Disease and Transplantation
- Brain Metastases and Treatment
- Obesity, Physical Activity, Diet
- Chronic Disease Management Strategies
- Hepatocellular Carcinoma Treatment and Prognosis
- Heart Failure Treatment and Management
- Esophageal and GI Pathology
- Peripheral Artery Disease Management
- Blood Pressure and Hypertension Studies
- Esophageal Cancer Research and Treatment
- Hepatitis B Virus Studies
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Soft tissue tumor case studies
- Liver Diseases and Immunity
- Nuclear Structure and Function
Mayo Clinic
2016-2024
University of Iowa
2016-2024
University of Iowa Health Care
2024
University of Iowa Hospitals and Clinics
2021-2024
Sterling Research Group
2024
The University of Texas MD Anderson Cancer Center
2024
WinnMed
2015-2022
Mayo Clinic in Arizona
2016-2020
Mayo Clinic in Florida
2015-2020
RELX Group (Netherlands)
2019
A pyramid has expressed the idea of hierarchy medical evidence for so long, that not all is same. Systematic reviews and meta-analyses have been placed at top this several good reasons. However, there are counterarguments to placement. We suggest another way looking evidence-based medicine explain how systematic tools consuming evidence—that is, appraising, synthesising applying evidence.
Funding for the development of this Practice Guideline and Guidance was provided by American Association Study Liver Diseases. Potential conflict interest: Dr. Mack consults Albireo. Kerkar advises High Tide received royalties from Elsevier. Manns for, is on speakers' bureau grants Falk. He Novartis. Vierling CymaBay, Enanta, Genkyotex, Intercept, Lilly, Novartis, TaiwanJ. Arena, BioIncept, Blade, GlaxoSmithKline Allergan NGM. What's New Since 2010 Guidelines? Histological features NAFLD are...
Red cell transfusions remain a mainstay of therapy for patients with sickle disease (SCD), but pose significant clinical challenges. Guidance specific indications and administration transfusion, as well screening, prevention, management alloimmunization, delayed hemolytic transfusion reactions (DHTRs), iron overload may improve outcomes.Our objective was to develop evidence-based guidelines support patients, clinicians, other healthcare professionals in their decisions about SCD the...
Sterling, Richard K.; Duarte-Rojo, Andres; Patel, Keyur; Asrani, Sumeet Alsawas, Mouaz; Dranoff, Jonathan A.; Fiel, Maria Isabel; Murad, M. Hassan; Leung, Daniel H.; Levine, Deborah; Taddei, Tamar Taouli, Bachir; Rockey, Don C. Author Information
Sterling, Richard K.; Patel, Keyur; Duarte-Rojo, Andres; Asrani, Sumeet Alsawas, Mouaz; Dranoff, Jonathan A.; Fiel, Maria Isabel; Murad, M. Hassan; Leung, Daniel H.; Levine, Deborah; Taddei, Tamar Taouli, Bachir; Rockey, Don C. Author Information